Prognostic role of hematologic parameters of metastatic renal cell carcinoma treated with sunitinib

CONCLUSIONS: In our cohort of patients with mRCC treated with sunitinib, low LMR (>3) and high PLR (>150) were associated with shorter PFS. Macrocytosis was not prognostic.PMID:34296630 | DOI:10.1177/03008916211033905
Source: Tumori - Category: Cancer & Oncology Authors: Source Type: research